128 related articles for article (PubMed ID: 32224314)
1. Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort.
Hansen CR; Bertelsen A; Zukauskaite R; Johnsen L; Bernchou U; Thwaites DI; Eriksen JG; Johansen J; Brink C
Radiother Oncol; 2020 Jun; 147():15-21. PubMed ID: 32224314
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.
Dean JA; Wong KH; Welsh LC; Jones AB; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
Radiother Oncol; 2016 Jul; 120(1):21-7. PubMed ID: 27240717
[TBL] [Abstract][Full Text] [Related]
3. Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.
Dean JA; Wong KH; Gay H; Welsh LC; Jones AB; Schick U; Oh JH; Apte A; Newbold KL; Bhide SA; Harrington KJ; Deasy JO; Nutting CM; Gulliford SL
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):820-831. PubMed ID: 27788955
[TBL] [Abstract][Full Text] [Related]
4. Radiobiological modeling of radiation-induced acute mucosal toxicity (oral mucositis and pharyngeal mucositis): A single-institutional study of head-and-neck carcinoma.
Singh B; Singh G; Oinam AS; Kumar V; Vashistha R; Sidhu MS; Singh M
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0-S1715. PubMed ID: 37147947
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report.
Nicolatou O; Sotiropoulou-Lontou A; Skarlatos J; Kyprianou K; Kolitsi G; Dardoufas K
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):551-6. PubMed ID: 9806514
[TBL] [Abstract][Full Text] [Related]
6. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
7. Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients.
Orlandi E; Iacovelli NA; Rancati T; Cicchetti A; Bossi P; Pignoli E; Bergamini C; Licitra L; Fallai C; Valdagni R; Cavallo A
Oral Oncol; 2018 Nov; 86():266-272. PubMed ID: 30409311
[TBL] [Abstract][Full Text] [Related]
8. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer.
Bensadoun RJ; Franquin JC; Ciais G; Darcourt V; Schubert MM; Viot M; Dejou J; Tardieu C; Benezery K; Nguyen TD; Laudoyer Y; Dassonville O; Poissonnet G; Vallicioni J; Thyss A; Hamdi M; Chauvel P; Demard F
Support Care Cancer; 1999 Jul; 7(4):244-52. PubMed ID: 10423050
[TBL] [Abstract][Full Text] [Related]
9. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.
Dean JA; Welsh LC; Wong KH; Aleksic A; Dunne E; Islam MR; Patel A; Patel P; Petkar I; Phillips I; Sham J; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):263-273. PubMed ID: 28057404
[TBL] [Abstract][Full Text] [Related]
10. Effect of low level helium-neon (He-Ne) laser therapy in the prevention & treatment of radiation induced mucositis in head & neck cancer patients.
Arun Maiya G; Sagar MS; Fernandes D
Indian J Med Res; 2006 Oct; 124(4):399-402. PubMed ID: 17159259
[TBL] [Abstract][Full Text] [Related]
11. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Oral Mucositis among Patients Undergoing Radiotherapy for Head and Neck Cancer: An Audit.
Luitel A; Rimal J; Maharjan IK; Regmee P
Kathmandu Univ Med J (KUMJ); 2019 Jan.-Mar; 17(65):61-65. PubMed ID: 31734681
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
Sangthawan D; Phungrassami T; Sinkitjarurnchai W
J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
[TBL] [Abstract][Full Text] [Related]
14. The effect of the use of thyme honey in minimizing radiation - induced oral mucositis in head and neck cancer patients: A randomized controlled trial.
Charalambous M; Raftopoulos V; Paikousis L; Katodritis N; Lambrinou E; Vomvas D; Georgiou M; Charalambous A
Eur J Oncol Nurs; 2018 Jun; 34():89-97. PubMed ID: 29784145
[TBL] [Abstract][Full Text] [Related]
15. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study.
Ertekin MV; Koç M; Karslioglu I; Sezen O
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):167-74. PubMed ID: 14697435
[TBL] [Abstract][Full Text] [Related]
16. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
17. Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.
Macann A; Fua T; Milross CG; Porceddu SV; Penniment M; Wratten C; Krawitz H; Poulsen M; Tang CI; Morton RP; Hay KD; Thomson V; Bell ML; King MT; Fraser-Browne CL; Hockey HU
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):572-9. PubMed ID: 24521675
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
19. Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
Moslemi D; Nokhandani AM; Otaghsaraei MT; Moghadamnia Y; Kazemi S; Moghadamnia AA
Radiother Oncol; 2016 Jul; 120(1):13-20. PubMed ID: 27113797
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
Narayan S; Lehmann J; Coleman MA; Vaughan A; Yang CC; Enepekides D; Farwell G; Purdy JA; Laredo G; Nolan K; Pearson FS; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):756-62. PubMed ID: 18417299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
